No photo of Ole Weiss Bjerrum

Ole Weiss Bjerrum

If you made any changes in Pure these will be visible here soon.

Research Output

Whole Blood Transcriptional Profiling Reveals Highly Deregulated Atherosclerosis Genes in Myeloproliferative Cancer

Skov, V., Kjær, L., Riley, C. H., Larsen, T. S., Weiss Bjerrum, O., Kruse, T., Hasselbalch, H. C. & Thomassen, M., Nov 2018, In : Blood. 132, Suppl. 1

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Whole Blood Transcriptional Profiling Reveals Highly Deregulated Atherosclerosis Genes in Myeloproliferative Cancer

Skov, V., Kjær, L., Riley, C. H., Larsen, T. S., Weiss Bjerrum, O., Kruse, T., Hasselbalch, H. C. & Thomassen, M., 3. Dec 2018.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

Mikkelsen, S. U., Kjær, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Skov, V., Andersen, C. B. L., Weiss Bjerrum, O., Brochmann Mortensen, N., El Fassi, D., Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Pallisgaard, N., Thomassen, M. & Hasselbalch, H. C., Jun 2018, In : EHA Learning Center. 2018, PF620.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

Mikkelsen, S. U., Kjær, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Skov, V., Andersen, C. B. L., Weiss Bjerrum, O., Brochmann Mortensen, N., El Fassi, D., Kruse, T., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Pallisgaard, N., Thomassen, M. & Hasselbalch, H. C., 15. Jun 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Molecular profiling reveals highly de-regulated insulin growth factor binding proteins in patients with myelofibrosis and related neoplasms

Skov, V., Thomassen, M., Kjær, L., Riley, C. H., Larsen, T. S., Weiss Bjerrum, O., Kruse, T. A. & Hasselbalch, H. C., 14. Jun 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., Larsen, T. S. & 1 others, Hasselbalch, H. C., Nov 2018, In : Blood. 132, Suppl. 1

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., Larsen, T. S. & 2 others, Hasselbalch, H. C. & Hasselbalch, H. C., 3. Dec 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Lægemidler med virkning ved maligne sygdomme

Laursen, B. E. & Weiss Bjerrum, O., 2019, Basal og klinisk farmakologi. Brøsen, K., Dalhoff, K. & Simonsen, U. (eds.). 6. ed. FADL's Forlag, p. 914-951

Research output: Chapter in Book/Report/Conference proceedingBook chapterEducationpeer-review

Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V. H., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., Larsen, T. S. & Hasselbalch, H. C., 15. Jun 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T. A., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V. H., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., Larsen, T. S. & 1 others, Hasselbalch, H. C., 15. Jun 2018, In : HemaSphere. 2, S1, p. 18-19 S131.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access
File
93 Downloads (Pure)

Interferon-alfa2 Treatment of Patients with Polycythemia Vera and Related Neoplasms Impacts Deregulation of Oxidative Stress Genes and Antioxidative Defence Mechanisms. Potential Implications of IFN-Alfa Induced Changes in TP53, NRF2 and CXCR4 for Genomic Instability and CD34+ Mobilisation.

Skov, V., Riley, C. H., Thomassen, M., Kjær, L., Larsen, T. S., Weiss Bjerrum, O., Kruse, T. A. & Hasselbalch, H. C., 3. Dec 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL

Andersen Patel, D., Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., Ellervik, C., el Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V., Lindholm Sørensen, A., Jesper, S., Starklint, J. & 4 others, de Stricker, K., Thomassen, M., Larsen, T. S. & Hasselbalch, H. C., Jun 2019, In : HemaSphere. 2019, PB2210.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Knudsen, T. A., Skov, V., Werner, L., Duke, W., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Lund Hansen, D., Larsen, T. S., Ellervik, C., El Fassi, D., de Stricker, K., Ocias, L. F., Brabrand, M., Weiss Bjerrum, O., Overgaard, U. M., Frederiksen, M., Kielsgaard Kristensen, T., Kruse, T. A. & 11 others, Thomassen, M., Mourits-Andersen, T., Severinsen, M. T., Jesper, S., Starklint, J., Møller, P., Neuberg, D. S., Kjær, L., Hasselbalch, H. C., Coleman Lindsley, R. & Mullally, A., 9. Dec 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Knudsen, T. A., Skov, V., Werner, L., Duke, W., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Lund Hansen, D., Larsen, T. S., Ellervik, C., El Fassi, D., de Stricker, K., Ocias, L. F., Brabrand, M., Weiss Bjerrum, O., Overgaard, U. M., Frederiksen, M., Kielsgaard Kristensen, T., Kruse, T. A. & 11 others, Thomassen, M., Mourits-Andersen, H. T., Severinsen, M. T., Jesper, S., Starklint, J., Møller, P., Neuberg, D. S., Kjær, L., Hasselbalch, H. C., Coleman Lindsley, R. & Mullally, A., 13. Nov 2019, In : Blood. 134, Supplement 1, 4202.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Eosinofili

Translated title of the contribution: EosinophiliaWeiss Bjerrum, O., El Fassi, D., Madsen, G., Jesper, S., Vestergaard, H., Rønnov-Jessen, D., Trøllund Pedersen, P., Pulczynski, S., Overgaard, U. M. & Andersen, C. L., 2019, In : Ugeskrift for Laeger. 181, 11, V01180032.

Research output: Contribution to journalJournal articleResearchpeer-review

Association of the blood eosinophil count with end-organ symptoms

Bjerrum, O. W., Siersma, V., Hasselbalch, H. C., Lind, B. & Andersen, C. L., 1. Sep 2019, In : Annals of Medicine and Surgery. 45, p. 11-18

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
117 Downloads (Pure)